Xylem Inc. (XYL) Stock Analysis

Price updated 4 days ago · SEC data refreshed 3 months ago · Not investment advice

Xylem Inc.

XYL Industrials Industrial Machinery📄 SEC filings ↗ CUSIP 98419M100
Overvalued by model
▾ What's in the 44/100 risk score? (higher = riskier)
Valuation (price vs model IV) (30%) 78/100 → +23.4
Fundamental health (30%) 24/100 → +7.2
leverage 20/100 · FCF trend 25/100 · DCF applicability 30/100 · Altman Z not scored — input unavailable (see Financial Health)
Smart money (short interest + insider buying) (22%) 31/100 → +6.8
Macro backdrop (VIX, curve, credit, fear/greed + week-over-week momentum) (18%) 35/100 → +6.3
early-warning: macro conditions deteriorating week-over-week
Total44/100

Contributions (weight × component score) sum to the total. This near-term score now includes fundamental health (leverage, FCF trend, DCF applicability). It excludes the Altman Z score, whose retained-earnings input this filer does not report separately. See the Financial Health section for the full balance-sheet read.

💵 Price $106.96 · 4 days ago 📄 Financials SEC EDGAR · refreshed 3 months ago

How to read XYL

A profitable, cash-generating business — our discounted-cash-flow estimate is the primary lens, cross-checked against what growth the price implies and against peers.

Where to start — the sections that matter most for this stock
  1. 1 The verdict + intrinsic value (our DCF) ↓
    Our estimate of what a share is worth, versus today's price.
  2. 2 Reverse-DCF + the interactive calculator ↓
    See the growth the price assumes, then flex every assumption yourself to pressure-test it.
  3. 3 Football field + peers ↓
    A cross-check across methods and against comparable companies.
Or — what are you trying to decide?
A note on process: fear-driven decisions — including fear of missing out — tend to be the expensive ones. A stock up 10% a day for three days is excitement, not evidence. Whichever reader you are, the data below is there to be checked before anything is decided.
🚀
"It's surging — should I chase it?"
The momentum / FOMO trade. Before you chase, see whether the people who know it best are quietly selling into the rally.
⚖️
"Is it worth what it costs?"
The valuation trade. Our DCF, the growth the price implies, and a calculator you drive yourself.
🏷️
"Is it a cheap bargain?"
The deep-value trade. How far below assets and our value it trades — and whether it's cheap for a reason.

Is now a good time to buy XYL?

Macro: Neutral / mid-cycle

XYL trades at $106.96 vs an estimated intrinsic value of $87.91 — a +21.7% premium to model IV. Today's price is consistent with XYL's owner-earnings free cash flow per share growing about 16.3% per year 5-YR · SCENARIO PATH over the next 5 years (the price-implied growth rate). Our DCF projects modeled growth of 12.2% per year based on history + sector defaults (analyst consensus estimates not yet integrated).
Note: this is a 5-year, per-share view. The Reverse-DCF section below asks the same question on a stricter 10-year free-cash-flow?Free Cash Flow (FCF) — Operating cash flow minus capital spending: cash left after a company covers operating costs, taxes and interest and reinvests in the business — but BEFORE repaying debt principal or paying dividends. The cash actually available to investors.
Why it matters: A company can show big profits on paper while burning through cash. FCF is what actually fills the bank account.
Reference: Healthy mature businesses convert 8–15% of revenue into FCF · Growth companies often negative
Full explanation →
basis — so its growth number is different, not contradictory.

▾ Exactly how this 5-year figure is computed
Starting FCF/share: $3.51 (TTM)
Current price: $106.96 (live)
Discount rate: 9.7%; terminal growth: 3.0%
Forecast: 5 years explicit growth, then a linear fade to terminal; end-of-period cash flows discounted to today
Growth path: the model's scenario-weighted path (conservative 40% / base 35% / optimistic 25% — assumed weights, not measured probabilities) — see the "Three Scenarios, Weighted" table below for the three IVs
Method: solve for the constant 5-year per-share growth rate that, run through this same structure, makes the intrinsic value equal today's price. (The 10-year figure below uses a flat 10-yr path instead — hence a different number.)

Margin of safety
None — price is above our value
Macro regime
Neutral / mid-cycle
No extreme readings in either direction. Stock selection matters more than macro positioning right now.

Not investment advice. The model can be wrong. Verify the assumptions in the sections below and consider consulting a licensed advisor for significant decisions.

What return would XYL pay as a bond?

Treat the share as a bond: the "coupon" is the cash an owner could take out this year, and unlike a real bond that coupon can grow. Fix today's price and a conservative growth path, and the only unknown left is the return. That number is comparable across every kind of company — which is the point.

Coupon today
$3.30 /sh
owner earnings — 3-year average of owner earnings (operating cash flow − all capex − stock comp) per current share
Starting yield
3.1%
coupon ÷ $106.96 price
Coupon growth used
12.2% /yr
the DCF's own stage-1 rate · fades to 2.5% by year 10
10-year return (IRR)
6.3%
Bond-like
XYL as an equity bond (15× exit)
6.3%
same, sold at 12× (pessimistic exit)
4.6%
same, sold at 20× (generous exit)
8.6%
10-year Treasury today
5.0%
Return our DCF demanded for this risk
9.7%

Plainly: at $106.96, XYL pays a 3.1% owner-earnings coupon today. If that coupon grows 12.2% a year for five years and then settles toward 2.5%, and a buyer in year 10 pays 15× that year's owner earnings, the whole trade returns about 6.3% a year — 1.3 points more than a Treasury with none of the business risk. By year 5 the coupon on today's price would be 5.5% (the "yield on cost" Buffett talks about). Our DCF demanded 9.7% for a business this risky; this read falls short of that bar, which is the same conclusion the verdict above reaches by a different route.

Track record: 5 of 5 reported years with positive owner earnings; the coupon itself grew 30.3%/yr across that record. Type: Grower (by growth used). Latest single-year owner earnings were $3.51/sh; the coupon above uses the model's 3-year average of owner earnings (operating cash flow − all capex − stock comp) per current share so one unusual year doesn't set the bond. Owner earnings here = operating cash flow − all capital spending − stock compensation (stricter than Buffett's maintenance-only capex), so growers that reinvest heavily read low on purpose. Buybacks are not added to growth. Hypothetical, before tax and fees; a model read, not a forecast. Compare every stock on this axis →
ⓘ Why does XYL trade at $106.96?

Xylem Inc. has 244.0 million shares outstanding. At $106.96 per share, the market values all outstanding XYL equity at $26.1 billion. That's market capitalization, not enterprise value — enterprise value also accounts for debt and cash. The share price by itself tells you almost nothing — a company can pick any share price by splitting or issuing more shares. What matters is the total value (Market Cap?Market Cap — The total dollar value the market is assigning to the entire company.
Why it matters: This is the number that actually matters when comparing companies. Two companies with the same business but different share counts have the same market cap.
Reference: Mega cap >$200B · Large $10–200B · Mid $2–10B · Small $300M–2B · Micro <$300M
Full explanation →
) compared to what the business actually produces. This page values XYL in Per Share?Per Share — A company-level figure divided by total shares — what one share represents.
Why it matters: Per-share metrics are the only way to fairly compare two companies with different share counts.
Full explanation →
economics — what each share represents of the underlying business. Play with the share-price calculator on the homepage →

Loading insider & short-seller data…
Checking filings for failure warnings…

What growth must the market believe? ?Reverse DCF — Instead of asking "what is this stock worth?", asks "what growth rate is the current market price already assuming?"
Why it matters: It crystallizes the bull thesis as a single number you can argue with. If the market expects 40% growth for 10 years and you do not believe that, the stock is overvalued.
Reference: 10–15% = sustainable for strong companies · 20–25% = exceptional · 30%+ = historically very rare

Traditional DCF asks "what is this stock worth?" Reverse DCF flips it: it treats today's price as correct and solves for the growth rate that justifies it. In plain terms — if our model is right about everything else, the company's cash flow would have to grow (or shrink) by this much every year for the next 10 years for today's price to make sense. If that required growth looks unrealistic, the price is stretched; if it looks easy to beat, the price may be cheap.

To justify today's $106.96 price, XYL's free cash flow?Free Cash Flow (FCF) — Operating cash flow minus capital spending: cash left after a company covers operating costs, taxes and interest and reinvests in the business — but BEFORE repaying debt principal or paying dividends. The cash actually available to investors.
Why it matters: A company can show big profits on paper while burning through cash. FCF is what actually fills the bank account.
Reference: Healthy mature businesses convert 8–15% of revenue into FCF · Growth companies often negative
Full explanation →
must grow at:
+12.2%
10-year flat FCF growth implied by today's price
This is a different figure from the 16.3% in the verdict at the top: that one is the 5-year implied per-share growth on the model's scenario-weighted path, while this is a 10-year flat rate. Different horizon and shape, so a different number — not a contradiction. Both are solved at today's live price.
▾ Exactly how this 10-year figure is computed
Starting FCF/share: $3.51 (TTM)
Forecast length: 10 years, single flat growth rate (no fade)
Terminal growth after year 10: 3.0%
Discount rate: 9.7% (the rate the model used)
Price used: $106.96 — the live price shown on this page (not frozen)
Method: solve for the constant annual growth rate that makes the discounted 10-year FCF stream + terminal value equal today's price.
Demanding

Above-average expectation. Achievable for genuinely strong compounders but the business needs to execute well.

For reference: Demanding — relatively few large companies sustain this pace of cash-flow growth for a full decade.

▾ How we computed this · Reality check thresholds · Assumptions
Inputs:
  • Starting FCF/share: $3.51 (TTM)
  • Discount Rate?Discount Rate — The annual return you demand for taking single-stock risk instead of buying a safe Treasury or index fund.
    Why it matters: Higher discount rate = stricter valuation (a stock has to produce more cash to be worth holding). Lower = more generous.
    Reference: 8–12% is standard · 9–10% matches S&P 500 historical return · Below 7% is illogical for single-stock risk
    Full explanation →
    : 9.7% — standard 8-12%; 9-10% matches S&P 500 historical return
  • Terminal Growth Rate?Terminal Growth Rate — The growth rate we assume the company holds forever, after the explicit 10-year forecast period ends.
    Why it matters: It anchors the long-tail value. Cannot mathematically exceed long-term GDP growth or the company eventually becomes larger than the global economy.
    Reference: 2–3% (matches long-term US GDP growth) · Above 4% is mathematically problematic
    Full explanation →
    : 3.0% — matches long-term GDP growth
  • Forecast horizon: 10 years explicit + terminal perpetuity
Reality-check scale:
≤ 0%Priced for decline — likely undervalued OR dying business
5-12%Reasonable; sustainable for quality businesses
12-18%Demanding — strong execution required
18-25%Exceptional — few companies sustain for a decade
25-35%Heroic — historically very rare
35%+Borderline impossible at scale

Sustaining 30%+ cash-flow growth for a full decade at scale is exceedingly rare — the bar is brutally high.

Use the interactive calculator below to change the discount rate, growth and terminal-growth assumptions and watch the value move.

Football field: where does the price sit?

Different valuation methods produce different fair-value ranges depending on assumptions. Plotting them together lets you see at a glance whether the current price is reasonable across approaches, or only one specific lens.

$28$65$102$140$177Current price $106.96If FCF grew -5%/yr → 18%/yr (flat 10-yr DCF sweep; model assumes 12.2%)$30.01$167.03Our model's scenarios (conservative → optimistic; ◆ base, ● weighted 40/35/25)$73.21$109.18weighted $87.91base $89.53
The current price sits inside each method's range — roughly fair on this blended view.

Industry multiples sourced from: sector: Industrials. See the Peer Basket section below for the peer comparison and its limited-comparables caveat.

How does XYL stack up against its closest peers?

We take the 7 same-industry companies most similar to XYL (similar size) and check what investors are paying for each dollar of their revenue (or profits). If XYL is much more expensive on the same yardstick, that's a red flag — unless you have a specific reason it deserves a premium. For a leveraged business, EV/EBIT and FCF yield (both in the table) are usually more reliable than EV/Sales, because revenue multiples ignore differences in margins and debt.

▾ What's "EV / Sales" in plain English?

EV (Enterprise Value) = market cap + total debt − cash. It's "what you'd pay to buy the entire company outright" — you pay the market cap to shareholders and take over their debt, but you keep their cash. EV is fairer than market cap alone because it includes the debt the new owner inherits.

EV / Sales = EV ÷ annual revenue. So "2.5×" means investors pay $2.50 of enterprise value per $1 of yearly sales. Higher = market is paying more per dollar of sales (usually because they expect future growth or fat margins).

p25 / median / p75 are the 25th, 50th (middle), and 75th percentile of the peers' multiples. Half the peers fall between p25 and p75. The median (p50) is the typical peer — that's the benchmark we compare to.

What peers trade at (p25 / median / p75)
EV / Sales?EV / Sales — For every $1 of yearly revenue, this is how many dollars investors pay to own the whole business (including debt).
Why it matters: Works for pre-profit growth companies where P/E and FCF don't apply. The most apples-to-apples cross-company multiple because it ignores accounting choices.
Reference: 1–3x for mature companies · 4–10x for software/SaaS · 10–20x for hypergrowth · >20x is rare and demanding
Full explanation →
3.7x / 5.0x / 6.4x
EV / Gross Profit?EV / Gross Profit — Enterprise value divided by gross profit — the multiple paid for what each dollar of sales contributes after direct costs.
Why it matters: More refined than EV/Sales for high-margin businesses (software, marketplaces) where gross margin is the real economic engine.
Reference: 8–15x for SaaS · 15–25x for hypergrowth software · >30x demanding
Full explanation →
8.4x / 11.0x / 12.7x
EV / EBIT?EV / EBITDA — Enterprise value divided by earnings before interest, tax, depreciation, and amortization.
Why it matters: A classic "what would a private buyer pay" multiple — used in M&A. Strips out tax and capital-structure noise.
Reference: 8–12x for mature businesses · 15–25x for growth · Below 5x often signals distress
Full explanation →
24.5x / 25.3x / 26.8x

Bold middle number = median peer. Half the peers trade above it, half below. Computed over 7 same-industry peers; implausible multiples excluded.

Peer-implied value check
$184.77
If XYL traded at the typical (median) peer's EV/Sales multiple, the share price would be about $184.77.
Plain English: the stock currently trades at $106.96. That's 42.1% LESS than peer multiples imply — the stock looks cheap vs peers. Either an opportunity, or the market sees something wrong with this name that doesn't apply to peers.

⚠️ Important caveat: peer multiples only work if the peers are genuinely comparable. Always check the peer list below — if the auto-picker grabbed micro-caps or unrelated businesses, the comparison is noise. A medical-device giant priced against tiny biotech startups won't produce a useful signal.

▾ View peer list (8)
Ticker Company Industry Mcap EV/Sales EV/GPEV/EBIT FCF Yield
IR Ingersoll Rand Inc. Industrial Machinery $28.0B 3.7x 8.4x24.5x 4.1%
RBC RBC Bearings INC Industrial Machinery $18.1B 10.1x 22.8x45.1x 2.1%
ITT ITT INC. Industrial Machinery $17.4B 4.5x 12.7x25.8x 3.3%
NDSN NORDSON CORP Industrial Machinery $16.0B 6.4x 25.3x 3.9%
IEX IDEX CORP /DE/ Industrial Machinery $15.6B 5.0x 11.3x24.9x 3.7%
RRX REGAL REXNORD CORP Industrial Machinery $13.4B 3.1x 8.2x26.8x 4.6%
GGG GRACO INC Industrial Machinery $12.5B 5.6x 10.7x20.0x 4.7%
SYM Symbotic Inc. Industrial Machinery ·fallback $28.0B 12.4x 66.2x 13.5%

Quality & solvency checks

Cheap stocks can be cheap for a reason. These screens warn when a low valuation comes paired with structural fragility.

Altman Z-Score?Altman Z-Score — A bankruptcy-risk score combining 5 financial ratios into one number. Predictive of bankruptcy within 2 years.
Why it matters: Cheap-looking stocks (low P/E or P/B) often have low Z-scores because the market knows the company is dying. Z-score warns you before you fall into a value trap.
Reference: > 3.0 = safe zone · 1.81–3.0 = grey zone · < 1.81 = distress zone
Full explanation →
n/a
Not reliably computable

We can't produce a trustworthy Altman Z here: retained earnings weren't separately reported in our data, so a core input would have to be fabricated. Rather than show a categorical "distress" verdict from an invented number, we mark it unavailable. Judge financial health from the leverage, cash position, and the measurable Piotroski checks instead.

Piotroski F-Score?Piotroski F-Score — A 9-point quality checklist scoring profitability, leverage, and operating efficiency.
Why it matters: High score = fundamentals improving. Low score = deteriorating. Especially powerful for filtering cheap stocks: cheap + high F-score historically outperforms; cheap + low F-score is often a value trap.
Reference: 7–9 = strong · 4–6 = mediocre · 0–3 = weak
Full explanation →
7 / 9
Strong
▾ The checks — what passed, what didn't (and what we couldn't measure)
  • Positive net income
    Net income $957.0M in FY2025.
  • Positive operating cash flow
    Operating cash flow $1,241.0M (was $1,263.0M the prior year).
  • Cash flow backs up reported profit
    Operating cash flow $1,241.0M vs net income $957.0M.
  • Return on assets improving
    Return on assets 5.4% vs 5.4% a year ago. Flat year-over-year — the point requires strict improvement, so it isn't awarded, but this is not deterioration.
  • Debt load (vs assets)
    Long-term debt is 11.1% of assets vs 12.0% a year ago ($1,954.0M of $17,634.0M assets).
  • Short-term liquidity (current ratio)
    Current ratio 1.63x vs 1.75x a year ago.
    Why this matters: The current ratio compares assets it can turn to cash within a year against bills due within a year. Below 1.0 means it may struggle to cover near-term obligations.
  • Share count (dilution)
    Share count held roughly flat (243.5M → 244.0M year-over-year).
  • Pricing power (gross margin)
    Gross margin 38.5% vs 37.5% a year ago.
  • Sales per asset (asset turnover)
    Asset turnover 0.51x vs 0.52x a year ago.
    Why this matters: Asset turnover measures how much revenue each dollar of assets generates. Rising = more productive use of the asset base.

Missing data is never counted as a pass or a fail — it's shown as n/a and excluded from the denominator. Each check compares the company against its own prior year.

What if you assume different inputs?

Here's where we land — and what happens if you change the assumptions. Drag the sliders to set your own Discount Rate?Discount Rate — The annual return you demand for taking single-stock risk instead of buying a safe Treasury or index fund.
Why it matters: Higher discount rate = stricter valuation (a stock has to produce more cash to be worth holding). Lower = more generous.
Reference: 8–12% is standard · 9–10% matches S&P 500 historical return · Below 7% is illogical for single-stock risk
Full explanation →
(the annual return you demand for single-stock risk) and terminal growth; the value updates live so you can see whether the stock looks cheaper or richer. The discount rate starts at 9.7%, the figure our model used for XYL. Open Advanced to also change beta, growth and the rate path.

Note: the calculator opens at our published value of $87.91 — it is initialised to the same scenario-weighted result, so the two match exactly on load. The moment you move a slider, the value below becomes a single-path what-if at your assumptions (not the three-scenario weighting), which is why it can differ from the headline once you've touched it.

Scenario-weighted model IV (40/35/25 assumed weights)
$87.91
It trades at
$106.96
Premium to model IV
+21.7%
Price is 22% above model IV — it looks overvalued. Change the assumptions below to see what would justify today's price.
We value this stock at two discount rates and report the range between them:
9.7% — beta-based (CAPM), from this stock's Beta?Beta — How much the stock moves when the overall market moves. 1.0 = moves with the market; 1.5 = moves 50% more than the market.
Why it matters: Higher beta = more volatile = should demand higher discount rate. Low beta stocks (utilities, consumer staples) move less.
Reference: Most stocks 0.5–1.5 · Defensives ~0.3 · High-vol tech ~1.5–2.0
Full explanation →
of 0.95.
The safe Treasury rate plus a premium scaled by how much more (or less) volatile the stock is than the market.
9.5% — sector/quality tier. A simpler hurdle set by industry and business durability: lower for stable, wide-moat companies; higher for speculative or micro-caps.
The headline value and this calculator start at 9.7% — the beta-based rate. Drag the slider to the other rate to see the full range.
4.5% (risk-free)9-10% normal18% (deep-risk)
0%2-3% (GDP)5% (rarely sustainable)
Value at your assumptions (opens at our published value; becomes a single-path what-if once you move a slider)
$87.91
vs today's $106.96
+21.7%

At the default assumptions the flat path lands near our published value of $87.91. Move any slider to recompute it with your own.

For comparison — the FCF growth today's price already assumes
+12.2%
at the default assumptions

Move any slider above to recompute this against your own assumptions.

⚙ Advanced — tinker with every input (beta, growth, rate path, margin → full intrinsic value)
Where the discount rate comes from — discount rate = risk-free + beta × equity-risk-premium
What you'd earn risk-free from government bonds — the floor under every other rate. Slide it down to model the market expecting rate cuts (value rises); up for higher-for-longer.
The extra yearly return investors demand for owning stocks instead of safe bonds — the price of risk. History runs ~4.5–6.5%; we default to 5.5% (slightly conservative). It's an estimate, not a law — lower it if you think equities are less risky than that.
Inflation reduces the purchasing power of a nominal return: a 9% gain at 3% inflation is about 6% in real terms. The intrinsic value above is already in today's dollars (a nominal DCF carries inflation in both the growth and the discount rate), so this switch does not change the value — it restates the return in real terms.
Higher beta → higher discount rate (sets the rate above). 1.0 = moves with the market.
What you think XYL can grow FCF for ~5 years, then fades to terminal.
All inputs start at the values our model used.

    Copy shareable link to this scenario →

    Price$106.96
    Model IV$87.91
    Premium to IV+21.7%
    DCF applicabilityHigh
    Implied Growth (5-yr)16.3%
    Return to IV (3yr, annualized)-6.3%
    To justify $107, XYL needs ~16.3% annual growth for 5 years — vs the model's 12.2%.

    Xylem Inc. (XYL) trades at a premium of +24.6% to its intrinsic value?Intrinsic Value — Our DCF model's estimate of what each share is mathematically worth based on projected cash flows.
    Why it matters: Compare to current price. Below IV = potentially undervalued. Above IV = priced for growth that must actually happen.
    Reference: Model-derived; quality depends on data and assumptions.
    Full explanation →
    , suggesting the market is paying up for its consistent revenue growth of 14.8%/yr and positive net income. However, the company's franchise/durability score of 2/5 indicates potential competitive challenges. The primary quantifiable risk is the implied growth rate of 16.3% needed to justify the current price, which is higher than its historical 14.8%/yr revenue growth.

    As of 3 months ago

    Anatomy of a share

    What you're buying per share. Bars are at the same scale so you can see the relative size of revenue, costs, cash flow, and debt — not just read them in a table.

    XYL Xylem Inc. stock anatomy showing per-share revenue, operating expenses, free cash flow, and debt
    10.6%
    profit
    Where each $1 of revenue goes
    Net profit — 10.6¢ of every dollar ($3.92/sh — latest fiscal-year net income per share)
    Costs & taxes — 89.4¢ (on $37.03 revenue/sh)
    Net margin = net income ÷ revenue (most recent fiscal year).
    Plain English: each share (at $107) represents $37.03 of revenue per share per year, $3.92 of net income per current share, and $3.51 of free cash flow per share from the latest fiscal year. Each share carries $8.01 of total debt (interest-bearing borrowings, current + long-term).
    What's free cash flow / what do these mean?

    Revenue per share — how much the business earns from customers, divided by the number of shares outstanding. Top of the income statement.

    Earnings per share — profit left after operating costs, interest, and taxes, per share. Two versions appear on this page and are not interchangeable: GAAP diluted EPS uses the company's weighted-average diluted share count during the reporting period (this is the "earnings" in "price-to-earnings"); net income per current share divides annual net income by today's share count. They differ whenever the share count has changed.

    Owner-earnings free cash flow per share — the cash the business produces for shareholders. Savng's owner-earnings FCF subtracts capital expenditures and stock-based compensation from operating cash flow (SBC is a real dilution cost even though it's non-cash). This is deliberately more conservative than "standard" FCF, which subtracts only capital expenditures — so our figure is lower than the headline FCF you'll see elsewhere. FCF funds dividends, buybacks, debt repayment, and acquisitions; a company can report positive earnings yet negative FCF.

    Debt per share — total interest-bearing borrowings divided by shares. High debt-per-share next to thin FCF-per-share is a fragility signal.

    What you actually need to decide

    Every stock price is a disagreement. Here's the single thing that must go right for the bulls, the single thing that breaks the thesis, and the concrete signposts to watch so you can update your view as real results arrive.

    🐂 The Bull Case
    For the stock to justify its premium, Xylem must sustain or accelerate its revenue growth beyond the historical 14.8%/yr, aligning with the market's implied 16.3% growth rate.
    🐻 The Bear Case
    The franchise/durability score of 2/5 suggests that competitive pressures could intensify, potentially hindering future growth and making it difficult to justify the current +24.6% premium.
    📌 Signposts to watch — update your view as these print
    • Next quarter's revenue growth rate
    • Changes in gross margin
    • Updates on long-term debt levels

    The trend, in plain numbers (FY2024 → FY2025, latest reported)

    Straight from the financial statements — no model, no opinion. For a small or unprofitable company, the direction of these numbers usually tells you more than any single valuation.

    ✅ Improving
    • Revenue grew +6% to $9.04B.
    • Gross margin improved to 38% (+1 pts).
    • Net income grew +8% to $957.0M.
    ⚠ Worsening
    • Free cash flow fell to $857.0M.

    Management & Leadership

    Patrick Decker has served as the CEO of Xylem Inc. since 2014, leading the company's global water technology solutions. He has overseen the company's expansion in addressing critical water and wastewater challenges worldwide.

    Patrick Decker
    Chief Executive Officer
    Sandra Rowland
    Chief Financial Officer
    Austin A. Alexander
    Chief Digital Officer

    What They Make

    Xylem Inc. designs, manufactures, and services engineered products and solutions for water and wastewater applications. Their products are sold to utilities, industrial, commercial, and residential customers globally.

    End Markets

    Public UtilitiesIndustrialCommercial & Residential

    Revenue Drivers

    Water infrastructure solutions
    Applied water systems
    Measurement & control technologies
    Market Cap: 26.1BBeta: 0.95

    Why Is It Priced Like This?

    Why Customers Pay

    Efficient water transport and treatment
    Reliable water quality monitoring
    Sustainable water resource management
    Intrinsic Value$87.91
    Premium to IV +21.7%
    Implied Growth (5-yr)16.3% Market prices 16.3% growth. Model: 12.2%.
    Return to IV (3yr, annualized) -6.3%

    The market prices XYL at a +24.6% premium, likely due to its consistent revenue growth of 14.8%/yr over four years and its track record of being profitable for five consecutive years. Investors appear to be optimistic about its ability to maintain this growth and profitability, despite a modest franchise/durability score of 2/5.

    Three Scenarios, Weighted
    ScenarioIVUpside from today's priceWeight
    Conservative$73.21-31.6%40%
    Base$89.53-16.3%35%
    Optimistic$109.182.1%25%
    Weighted$87.91-17.8%100%

    Reading the last column: it is the move from today's price to each value (IV ÷ price − 1). The headline "premium/discount to model IV" measures the same gap from the value's side (price ÷ IV − 1), so the two percentages differ in size and sign by construction — e.g. a price 8% above value is a value 7.4% below price.

    Business Model & Valuation

    How They Make Money

    Sales of pumps, valves, and treatment equipment
    Revenue from analytical instrumentation and services
    Digital solutions for water management

    Long-term debt has been falling from $2440M to $1954M, indicating a focus on debt reduction.

    Free Cash Flow DCF High

    Standard FCF DCF: positive free cash flow in a sector suited for cash-flow-based valuation.

    In plain English: we estimate XYL's value by projecting its owner-earnings free cash flow (operating cash flow minus capital expenditure and stock-based compensation) into the future and converting it back to what it's worth today. We start from $3.51 per share, assume it grows 12.2% per year for about 5 years (then gradually fades), and discount everything at 9.7% — the yearly return a buyer should demand for this much risk. After that it's assumed to grow 3.0% per year forever (roughly the long-run pace of the whole economy). A higher discount rate or slower growth means a lower value, and vice-versa — change any of these yourself in the calculator above.
    Owner-earnings FCF / share$3.51
    Growth (g₁) — 5yr12.2%Source: blend(70% revenue cagr, 30% sector)
    Discount Rate (r)9.7%
    Terminal Growth (gT)3.0%
    Show advanced inputs
    Revenue Growth14.8%
    Eps Growth13.6%
    Historical Fcf Growth30.3%
    Sector Default6.0%
    Best Estimate12.2%
    Methodblend(70% revenue_cagr, 30% sector)
    Growth Basistotal

    What this model does NOT do: this is a consolidated owner-earnings FCF model. Standalone segment assumptions: none. It does not project its revenue segments independently; their combined effect is embedded in the historical revenue and cash-flow trend the model extrapolates. The calculator above can only approximate a segment's impact through the single consolidated growth rate — it cannot model any one line separately. For a true segment-level view, build a separate model from the company's segment disclosures.

    Maturity & Competitive Position

    Mature compounder

    Moat Signals

    Extensive product portfolio for water cycle
    Global distribution and service network
    R&D in advanced water technologies

    Revenue has grown consistently at 14.8%/yr over four years, from $5195M to $9035M.

    Geography & Markets

    Xylem Inc. operates globally, providing water technology solutions across various continents. While specific geographic mix percentages are not available, it has a significant presence in North America, Europe, and emerging markets.

    Geographic Risks

    Global economic downturn impacting infrastructure spending
    Regulatory changes in water and wastewater treatment

    Market Signals

    These are timing signals, not value signals — they describe the stock's recent price behavior, not what the business is worth. Use them for the "the thesis looks good, but is now the moment?" question. Each tile below explains what it's saying.

    Model bearish, tape bearish - aligned.
    RSI?RSI — Relative Strength Index — a 0-100 momentum gauge. Above 70 = overbought; below 30 = oversold.
    Why it matters: Short-term contrarian indicator. Extreme readings often precede mean reversion, though not always.
    Reference: 30–70 normal · >70 overbought · <30 oversold
    Full explanation →
    (14)
    39.8NeutralMomentum is balanced — neither overbought nor oversold.
    MACD?MACD — Moving Average Convergence Divergence — compares a fast and a slow price trend to gauge momentum direction.
    Why it matters: When the fast line crosses above the slow line, short-term momentum is turning up; below, turning down. A timing cue, not a value signal.
    Reference: Line above signal = bullish momentum · below = bearish
    Full explanation →
    BullishLine above signalThe fast trend is above the slow trend — short-term momentum is currently upward.
    50-Day Average$117.81Price below (-9.2%)Price below its 50-day average = near-term downtrend.
    200-Day Average$134.22Price belowThe 200-day line is the long-term trend divider — above it is generally considered a bull market for the stock.
    50 vs 200 CrossDeath50-day below 200-dayA "death cross" — the medium trend is below the long trend (often read as bearish).

    Technicals describe price, not the business. A great company can have a "bearish" tape (a buying chance) and a weak one a "bullish" tape (a trap). Pair these with the valuation and health sections above.

    Financial Statements (5-year tables — click to expand)

    From Xylem Inc.'s SEC filings (EDGAR).

    Income (5yr)

    YearRevenueNet IncomeEPS
    20259.0B957.0M$3.92
    20248.6B890.0M$3.65
    20237.4B609.0M$2.79
    20225.5B355.0M$1.96
    20215.2B427.0M$2.35

    Cash Flow (5yr)

    YearOperating CFCapEx− SBC & adj.Free Cash Flow
    2025 1.2B 331.0M 53.0M 857.0M
    2024 1.3B 321.0M 56.0M 886.0M
    2023 837.0M 271.0M 60.0M 506.0M
    2022 596.0M 208.0M 37.0M 351.0M
    2021 538.0M 208.0M 33.0M 297.0M

    How we define FCF: operating cash flow − capital expenditure − stock-based compensation (owner-earnings basis — SBC is a real cost to shareholders even though it's non-cash). Latest year: 1.2B − 331.0M − 53.0M (SBC & adj.) = 857.0M. This is the same owner-earnings FCF definition the valuation model uses.

    Balance Sheet

    Total Assets17.6B
    Total Liabilities5.9B
    Equity11.5B
    Total Debt2.0B

    Similar companies worth a look

    Same sector and industry, similar fundamentals shape. Verify everything yourself — this list is computed mechanically and does not reflect our judgment about whether any of these are a good investment.

    PG
    Methodology by Pouyan Golshani, MD — founder of Gighz. Savng was built by a physician for busy professionals: every number on this page comes from SEC filings (EDGAR) and FINRA data through transparent, rules-based models — no analyst opinions, no hidden inputs. How we calculate every number →
    ⚠️ Not investment advice. Automated model outputs, last refreshed May 30, 2026 (the analysis-refresh date, not the latest filing period). All models have blind spots. Full disclaimer →
    🔔 Follow $XYL — free insider alerts
    One email when an insider buys $XYL on the open market with their own cash — or notably sells outside a scheduled plan. Routine and automated trades filtered out. Follow up to 3 stocks free; Portfolio Watch covers your whole list plus valuation & risk alerts. Double opt-in, unsubscribe anytime.